What does CUSIP 00182C103 represent in this 13F holders report?

CUSIP 00182C103 is the security identifier for ANIP - ANI PHARMACEUTICALS INC - Common Stock used to aggregate holder disclosures.

How many institutions held ANIP - ANI PHARMACEUTICALS INC - Common Stock in Q4 2018?

158 institutional investors reported ANIP - ANI PHARMACEUTICALS INC - Common Stock for Q4 2018. Use the holders table for investor-level position and value details.

ANI PHARMACEUTICALS INC - Common Stock (ANIP)

CUSIP: 00182C103

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class: Equity / Common Stock
Shares outstanding: 22,278,088
Total 13F shares: 7,079,477
Share change: -354,896
Total reported value: $318,725,901
Put/Call ratio: 55%
Price per share: $45.02
Number of holders: 158
Value change: -$18,340,193
Number of buys: 65
Number of sells: 83

Quarterly Holders Quick Answers

What is CUSIP 00182C103?
CUSIP 00182C103 identifies ANIP - ANI PHARMACEUTICALS INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2019
Previous quarter: Q3 2018

Recent filing periods for CUSIP 00182C103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ANIP - ANI PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	6.2%	1,386,354	$78,384,000	—	30 Sep 2018	13F
VANGUARD GROUP INC	13F	Company	2.3%	522,813	$29,559,000	—	30 Sep 2018	13F
MANGROVE PARTNERS IM, LLC	13F	Company	2.3%	512,401	$28,971,000	—	30 Sep 2018	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	2.3%	511,881	$28,941,000	—	30 Sep 2018	13F
LSV ASSET MANAGEMENT	13F	Company	1.3%	294,900	$16,673,000	—	30 Sep 2018	13F
NOMURA HOLDINGS INC	13F	Company	1.2%	277,009	$15,550,000	—	30 Sep 2018	13F
STATE STREET CORP	13F	Company	1.2%	270,474	$15,298,000	—	30 Sep 2018	13F
FIRST MANHATTAN CO. LLC.	13F	Company	0.97%	215,695	$12,195,000	—	30 Sep 2018	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.8%	178,400	$10,087,000	—	30 Sep 2018	13F
Invesco Ltd.	13F	Company	0.78%	174,083	$9,843,000	—	30 Sep 2018	13F
DEUTSCHE BANK AG\	13F	Company	0.75%	166,463	$9,412,000	—	30 Sep 2018	13F
Consonance Capital Management LP	13F	Company	0.64%	142,943	$8,082,000	—	30 Sep 2018	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.63%	140,658	$7,952,000	—	30 Sep 2018	13F
Bank of New York Mellon Corp	13F	Company	0.6%	134,115	$7,583,000	—	30 Sep 2018	13F
NORTHERN TRUST CORP	13F	Company	0.53%	118,091	$6,676,000	—	30 Sep 2018	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.47%	105,805	$5,983,000	—	30 Sep 2018	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.47%	104,904	$5,931,000	—	30 Sep 2018	13F
Phocas Financial Corp.	13F	Company	0.43%	96,805	$5,473,000	—	30 Sep 2018	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.42%	94,632	$5,350,000	—	30 Sep 2018	13F
Matarin Capital Management, LLC	13F	Company	0.38%	84,972	$4,804,317	—	30 Sep 2018	13F
Cortina Asset Management, LLC	13F	Company	0.33%	73,218	$4,140,000	—	30 Sep 2018	13F
Ranger Investment Management, L.P.	13F	Company	0.32%	70,212	$3,970,000	—	30 Sep 2018	13F
JPMORGAN CHASE & CO	13F	Company	0.3%	67,713	$3,829,000	—	30 Sep 2018	13F
Allianz Asset Management GmbH	13F	Company	0.3%	67,204	$3,800,000	—	30 Sep 2018	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.3%	66,797	$3,777,000	—	30 Sep 2018	13F
Triarii Capital Management LP	13F	Company	0.29%	65,000	$3,675,000	—	30 Sep 2018	13F
CADENCE CAPITAL MANAGEMENT LLC	13F	Company	0.25%	55,384	$3,131,000	—	30 Sep 2018	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.22%	48,667	$2,752,000	—	30 Sep 2018	13F
Regent Investment Management LLC	13F	Company	0.21%	46,439	$2,626,000	—	30 Sep 2018	13F
ARGENT CAPITAL MANAGEMENT LLC	13F	Company	0.21%	45,760	$2,587,000	—	30 Sep 2018	13F
CITIGROUP INC	13F	Company	0.19%	41,574	$2,350,000	—	30 Sep 2018	13F
Skandinaviska Enskilda Banken AB (publ)	13F	Company	0.18%	40,500	$2,290,000	—	30 Sep 2018	13F
TEACHERS ADVISORS, LLC	13F	Company	0.18%	39,970	$2,260,000	—	30 Sep 2018	13F
CHICAGO EQUITY PARTNERS LLC	13F	Company	0.18%	39,558	$2,237,000	—	30 Sep 2018	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.17%	38,355	$2,168,000	—	30 Sep 2018	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.17%	36,845	$2,083,000	—	30 Sep 2018	13F
Dana Investment Advisors, Inc.	13F	Company	0.15%	33,974	$1,921,000	—	30 Sep 2018	13F
PERKINS CAPITAL MANAGEMENT INC	13F	Company	0.15%	32,950	$1,863,000	—	30 Sep 2018	13F
Weiss Asset Management LP	13F	Company	0.15%	32,565	$1,841,000	—	30 Sep 2018	13F
VIRGINIA RETIREMENT SYSTEMS ET Al	13F	Company	0.14%	32,100	$1,815,000	—	30 Sep 2018	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.14%	30,392	$1,719,000	—	30 Sep 2018	13F
CORNERCAP INVESTMENT COUNSEL INC	13F	Company	0.13%	29,760	$1,683,000	—	30 Sep 2018	13F
1492 Capital Management LLC	13F	Company	0.13%	29,586	$1,673,000	—	30 Sep 2018	13F
KBC Group NV	13F	Company	0.13%	28,957	$1,637,000	—	30 Sep 2018	13F
ALGERT GLOBAL LLC	13F	Company	0.12%	27,295	$1,543,000	—	30 Sep 2018	13F
RICE HALL JAMES & ASSOCIATES, LLC	13F	Company	0.12%	26,192	$1,481,000	—	30 Sep 2018	13F
York State Teachers Retirement System New	13F	Individual	0.11%	25,528	$1,443,000	—	30 Sep 2018	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.11%	25,500	$1,442,000	—	30 Sep 2018	13F
THB ASSET MANAGEMENT	13F	Company	0.11%	25,156	$1,422,000	—	30 Sep 2018	13F
SMITH ASSET MANAGEMENT GROUP LP	13F	Company	0.11%	23,960	$1,355,000	—	30 Sep 2018	13F

Institutional Holders of ANI PHARMACEUTICALS INC - Common Stock (ANIP) as of Q4 2018

As of 31 Dec 2018, ANI PHARMACEUTICALS INC - Common Stock (ANIP) was held by 158 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,079,477 shares. The largest 10 holders included BlackRock Inc., MANGROVE PARTNERS, Vanguard Group Inc, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, FIRST MANHATTAN CO, INVESTMENT COUNSELORS OF MARYLAND LLC, RENAISSANCE TECHNOLOGIES LLC, Consonance Capital Management LP, and Bank of New York Mellon Corp. This page lists 158 institutional shareholders reporting positions in this security for the Q4 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2018 vs Q3 2018 Across Filers

Q3 2018 holders

164

Q4 2018 holders

158

Holder diff

-6

Investor	Q3 2018 Shares	Q4 2018 Shares	Share Diff	Share Chg %	Q3 2018 Value $	Q4 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.